SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-20-001036
Filing Date
2020-04-21
Accepted
2020-04-21 08:15:12
Documents
2
Period of Report
2020-04-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-04212020_080401.htm 8-K 16969
2 ex99-04212020_080408.htm EX-99 29742
  Complete submission text file 0001415889-20-001036.txt   47910
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 20804021
SIC: 2834 Pharmaceutical Preparations